Instem Revenue and Competitors

License our Company Data API

N/A

Total Funding

Estimated Revenue & Valuation

Instem's estimated annual revenue is currently $100.5M per year.(i)
Instem received $2.6M in venture funding in February 2009.
Instem's estimated revenue per employee is $184,150

Employee Data

Instem has 546 Employees.(i)
Instem grew their employee count by 2% last year.

Instem's People

Name	Title	Email/Phone
1 Phil Reason	CEO	Reveal Email/Phone
2 Jon Horton	Corporate VP, Investor Relations	Reveal Email/Phone
3 William Qubeck	VP, Consulting & Enterprise Hosting	Reveal Email/Phone
4 Chris Olinger	VP Technology and Innovation	Reveal Email/Phone
5 Stephen Baker	SVP, Clinical Trial Acceleration	Reveal Email/Phone
6 Gregor Grant	EVP	Reveal Email/Phone
7 John Anderson-C...	V.P. Sales	Reveal Email/Phone
8 Mike Harwood	EVP, Regulatory Solutions	Reveal Email/Phone
9 Gary Mitchell	VP, Global Marketing	Reveal Email/Phone
10 Paul Bradley	VP, Data Science Solutions	Reveal Email/Phone

Instem Competitors & AlternativesAdd Company

Competitor Name	Revenue	Number of Employees	Employee Growth	Total Funding	Valuation
#1 Medidata Soluti...	$668.1M	3222	3%	$20M	N/A
#2 OpenClinica	$5.3M	46	N/A	N/A	N/A
#3 Forte Research ...	$5.1M	46	-13%	$950K	N/A
#4 Bio-Optronics	$1.7M	23	-4%	$30M	N/A
#5 Data and Resea...	$0.7M	9	N/A	N/A	N/A
#6 Crucial Data So...	$0.7M	9	N/A	N/A	N/A
#7 Fortress Medica...	$0.6M	8	N/A	N/A	N/A
#8 RealTime-CTMS S...	$2.5M	25	N/A	N/A	N/A
#9 Axiom Real-Time...	$71M	300	-3%	N/A	N/A
#10 InfoEd Global	$14.2M	98	N/A	N/A	N/A
#11 PerkinElmer	$5060M	7612	-20%	$6.9M	$22.5B
#12 DATATRAK Intern...	$53.7M	302	7%	$8M	N/A
#13 ClinCapture	$3.8M	33	N/A	N/A	N/A
#14 ClinPlus	$4.2M	21	N/A	N/A	N/A
#15 Octalsoft - Glo...	$7.6M	58	32%	N/A	N/A
#16 Document Soluti...	$25.7M	161	N/A	N/A	N/A
#17 ERT	$1167M	5806	N/A	N/A	N/A
#18 S-Clinica	$16.5M	82	N/A	N/A	N/A
#19 Clinical Resear...	$12.7M	91	-9%	$17.2M	N/A
#20 KINETIQ LTD	N/A	39	N/A	N/A	N/A

Add Company

Show More Tech Services Companies

What Is Instem?

Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products. Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information. Instem supports its clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.

keywords:Biotechnology,Healthcare,Information Security,Pharmaceuticals,Security

N/A

Total Funding

546

Number of Employees

$100.5M

Revenue (est)

Employee Growth %

N/A

Valuation

N/A

Accelerator

Instem News

2022-04-17 - Instem Shares Fall as 2022 Expectations Hit by Wage Inflation

By Jaime Llinares Taboada. Shares in Instem PLC fell Tuesday after the company said that it is lowering its expectations for 2022 due to...

2022-04-17 - IN BRIEF: Instem shares dive as annual revenue lower than ...

Instem PLC - IT solutions provider based in Staffordshire, England - Posts slightly lower annual revenue than expected for 2021,...

2022-04-17 - Acquisitions have changed scale, reach and breadth of business says Instem"s CEO

Phil Reason, Instem's chief executive, talks through the latest results for the pharma services group with Proactive.

2021-09-29 - Instem : Appointment of Independent Non-Executive Director

29 September 2021 Instem plc ("Instem") Appointment of Independent Non-Executive Director Instem plc (AIM: INS), a leading provider of IT solutions to the global life sciences market, announces that it has appointed Riaz Bandali as an independent non-executive director to the Board effective ...

2021-09-28 - Instem : Grant of PDMR Options

28 September 2021 Instem plc ("Instem", the "Company") Grant of PDMR Options Instem plc (AIM: INS), a leading provider of IT solutions to the global life sciences market, announces that Phil Reason (Chief Executive Officer) and Nigel Goldsmith (Chief Financial Officer) have each been granted ...